Bu Shang Pharmaceutical: Intends to increase the capital of its wholly-owned subsidiary Bu Shang Sheng Yuan Medical by 3 million yuan.

Bosson Pharmaceuticals announced that on December 12, 2025, the company signed the "Capital Increase Agreement for Jinan Boshang Shengyuan Medical Devices Co., Ltd." with relevant parties. The company plans to increase its capital by a total of 3 million yuan to Boshang Shengyuan Medical Devices at a price of 1 yuan per share according to the existing shareholding proportions with other shareholders, with the company contributing 2.7 million yuan. After the capital increase is completed, the registered capital will increase from 10 million yuan to 13 million yuan, and the company's shareholding ratio will be 90%. All parties agree to complete the business registration change within 20 working days after the agreement takes effect, and the company and other shareholders will pay the increased capital within 5 years after the registration is completed. This capital increase will enhance the competitiveness of the subsidiary and have a positive impact on the long-term development of the company.